Trial intelligence / Profile preview

Effect of metformin and clomiphene in obese hypogonadal men with or without type 2 diabetes

2011-000439-10Phase 3Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metformin and clomiphene in type 2 diabetes mellitus (T2DM), Hypogonadism and obesity, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Plasma testosterone levels. Started Mar 2012; status: completed.

02

Drugs

metforminclomiphene
03

Conditions

type 2 diabetes mellitus (T2DM)Hypogonadismobesity

Beyond the preview

Go deeper on 2011-000439-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000439-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call